Eli Lilly & Co. (NYSE:LLY) - Page 2

lilly-logo

What to Expect From Eli Lilly Earnings

Eli Lilly and Co. (NYSE: LLY) is scheduled to report its third-quarter earnings before the markets open on Thursday. The consensus estimates from Thomson Reuters call for $0.75 in earnings ...
Read Full Story »
Bee

6 Big Companies That Severely Stung Shareholders This Past Week

This past week looked decent and kept the bulls interested, but the reality is that the market lacked much of the strength of the prior week. Two weeks in a ...
Read Full Story »
Eli Lilly Logo

Eli Lilly Stumbles on Discontinued Drug Trial

Eli Lilly and Co. (NYSE: LLY) was a pharmaceutical stock that was becoming much loved again due to the promise shown in studies of its diabetes and Alzheimer's drugs. Now ...
Read Full Story »
upgrade

Why Cholesterol and Alzheimer’s Could Drive Eli Lilly Shares Much Higher

Eli Lilly and Co. (NYSE: LLY), known as one of the powerhouses in the pharmaceutical industry, has just been given another boost by a key analyst. Credit Suisse sees solid ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: AT&T, BioCryst, Eli Lilly, Facebook, Flextronics, Gap, Tesla and More

Stocks were up yet again on Friday, making for one serious move, with the Dow up about 1,000 points from the lows of just last Friday. Investors have proven over and ...
Read Full Story »
Eli Lilly Logo

UBS Makes Big Biotech and Pharmaceutical Additions to Equity Focus List

If there was ever a time when investors are thrilled to see the calendar change it could be now. With the fourth quarter just starting, many are more than relieved ...
Read Full Story »
Big-Mac

4 Top Merrill Lynch US Defensive Stock Ideas for Q4

Just finishing up the worst quarter in the stock market in four years has left a pretty unpleasant taste not only in investors' mouths, but in the mouths of many ...
Read Full Story »
coal train

Merrill Lynch Makes Changes to US 1 List Amid Market Turmoil

As market pressures continue, investors are hammered with pundits now saying either the sky is falling or we are just in a bull market correction. One thing we know for ...
Read Full Story »
White House South Lawn, Blue Sky, Washington, DC, USA

Merrill Lynch Has 4 Pharma Stocks to Buy Against Political Chatter

When presidential candidate Hillary Clinton stirred the market this week with a campaign announcement on a proposed crackdown on drug pricing, and more regulations on the pharmaceutical industry, many of ...
Read Full Story »
thumbs up

Why Merrill Lynch Sees More Upside in Eli Lilly

In light of the recent Eli Lilly and Co. (NYSE: LLY) study surrounding Jardiance (empagliflozin), analysts are pouring in to the stock after it announced that Jardiance showed a sharp ...
Read Full Story »
Eli Lilly Logo

History Says Market Could Retest Lows: 4 Safe Stocks to Buy

The gut-wrenching drop back in August, when the Dow opened down 1,000 points and the indexes went through the first 10% correction in almost four years was, needless to say, ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Aetna, Eli Lilly, Gilead, Royal Gold, Sirius XM and Many More

Stocks were handily lower Friday morning after Janet Yellen and the Federal Open Market Committee (FOMC) decided to keep zero interest rates here for just a tad longer. The one ...
Read Full Story »
Eli Lilly Logo

Eli Lilly Continues to Rise on Positive Jardiance Results

Eli Lilly and Co. (NYSE: LLY) shares got a solid boost in the market Thursday morning as the broad markets were selling off. In fact this major pharmaceutical company has ...
Read Full Story »
coffee cup

Merrill Lynch US 1 List Update: Momentum Stock Panera Bread Is Out

Uh oh, it seems as though some of the portfolio strategists are maybe starting to get a little nervous as the summer winds down and the danger months of September ...
Read Full Story »
Prescription drugs

4 Top Pharma Stocks That Should Outperform Out To 2016

With a very nervous market, and the end of summer doldrums upon us, it may be time to look for ideas that will make sense when the market heats back ...
Read Full Story »